ANC coverage: one or more visits · pregnant women
One intervention probably leads to higher ANC coverage: one or more visits compared with no intervention (moderate certainty).
1 finding from 1 review
ANC coverage: four or more visits · pregnant women
One intervention leads to higher ANC coverage: four or more visits compared with no intervention (high certainty).
1 finding from 1 review
Pregnancy‐related deaths · pregnant women
One intervention showed no clear difference in pregnancy‐related deaths compared with no intervention (low certainty).
1 finding from 1 review
Deliveries in a health facility · pregnant women
One intervention leads to higher deliveries in a health facility compared with no intervention (high certainty).
1 finding from 1 review
Perinatal mortality · pregnant women
One intervention showed no clear difference in perinatal mortality compared with no intervention (moderate certainty).
1 finding from 1 review
Low birthweight · pregnant women
One intervention showed no clear difference in low birthweight compared with no intervention (high certainty).
1 finding from 1 review
Intermittent Prophylactic Treatment for malaria · pregnant women
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · COPD and at least one other long‐term condition
It is very uncertain whether intervention changes exacerbations ‐ number of people experiencing one or more  compared with usual care (very low certainty).
1 finding from 1 review
Hospital admissions · COPD and at least one other long‐term condition
Intervention showed no clear difference in all‐cause hospital admissions ‐ people experiencing one or more  compared with usual care (low certainty).
1 finding from 1 review
Objective measure of medication adherence: Cholesterol (low‐density lipoprotein) · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Objective measure of medication adherence: Blood pressure · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Combined cardiovascular events · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Adverse events · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Cognitive outcome: satisfaction with treatment · people prescribed medication for primary prevention of cardiovascular disease
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · the management of chronic obstructive pulmonary disease
It is very uncertain whether multi‐component intervention changes exacerbations: number of people experiencing at least one exacerbation compared with other intervention or routine, usual care or control treatment (very low certainty).
1 finding from 1 review
Physical activity · children aged 3 to 11 years
1 finding from 1 review
Time in MVPA · children aged 3 to 11 years
1 finding from 1 review
Children's percentage of total energy intake from saturated fat Measured by food frequency questionnaire and 24‐hour recall · children aged 7 to 18 years
1 finding from 1 review
Children's sodium intake (g/d) measured by food record Assessed at end of intervention (9 months) · children aged 7 to 18 years
1 finding from 1 review
Adverse effects (not reported by intervention arm) · children aged 4 to 14 years
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found